Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,000
Closed -$1.53M 143
2025
Q3
$1.53M Hold
28,000
0.81% 37
2025
Q2
$1.49M Sell
28,000
-2,000
-7% -$102K 0.78% 40
2025
Q1
$1.3M Buy
30,000
+6,000
+25% +$304K 0.82% 37
2024
Q4
$1.35M Buy
24,000
+6,000
+33% +$373K 0.78% 44
2024
Q3
$1.23M Sell
18,000
-7,500
-29% -$423K 0.78% 48
2024
Q2
$1.08M Buy
25,500
+6,500
+34% +$358K 0.7% 51
2024
Q1
$1.31M Buy
+19,000
New +$1.2M 0.9% 38

Other funds holding EXAS

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s EXAS Position: Q4 2025 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 28,000 shares — an estimated $1.53M sold.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in EXAS in Q1 2024 and held it in 7 quarters. The position peaked at $1.53M in Q3 2025. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 28,000 Exact Sciences shares in Q4 2025, an estimated $1.53M.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Exact Sciences in Q1 2024 and held it in 7 quarters.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Exact Sciences position peaked at $1.53M in Q3 2025.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q4 2025, filed 26 Jan 2026.